Ultime notizie per Bionano Genomics (NASDAQ:BNGO) Azioni

Bionano Genomics

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Bionano Genomics Inc

Guggenheim analyst Michael Morris maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Buy and raises the price target from $120 to $140.

News

Price Target

Analyst Ratings

Guggenheim Maintains Buy on Walt Disney, Raises Price Target to $140

UBS analyst William Appicelli maintains Talen Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLN#NASDAQ">TLN</a>) with a Buy and raises the price target from $296 to $366.

UBS Maintains Buy on Talen Energy, Raises Price Target to $366

Hovde Group analyst David Bishop initiates coverage on S&amp;T Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBA#NASDAQ">STBA</a>) with a Market Perform rating and announces Price Target of $41.

Initiation

STBA

Hovde Group Initiates Coverage On S&T Bancorp with Market Perform Rating, Announces Price Target of $41

UBS analyst Batya Levi maintains Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Buy and raises the price target from $680 to $895.

SPOT

UBS Maintains Buy on Spotify Technology, Raises Price Target to $895

Goldman Sachs analyst Alexander Blostein upgrades Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) from Neutral to Buy and announces $29 price target.

Upgrades

Goldman Sachs Upgrades Franklin Resources to Buy, Announces $29 Price Target

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Evercore ISI Group analyst Mark Mahaney upgraded The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) from In-Line to Outperform and maintained the price target of $90. Trade Desk shares closed at $68.02 on Thursday. <a href="https://www.benzinga.com/quote/TTD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Michelle Fang upgraded New Oriental Education &amp; Technology Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) from Neutral to Buy and lowered the price target from $77 to $50. New Oriental Education shares closed at $54.48 on Thursday. <a href="https://www.benzinga.com/quote/EDU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities analyst Andrew Boone upgraded the rating for Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) from Market Perform to Market Outperform and maintained the price target of $220. Alphabet shares closed at $173.54 on Thursday. <a href="https://www.benzinga.com/quote/GOOGL/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying GOOGL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="564" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27092004/image-424-1024x564.png" alt="" class="wp-image-964909" style="width:667px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27092004/image-424-1024x564.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27092004/image-424-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27092004/image-424-768x423.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27092004/image-424.png 1123w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46115042/top-2-tech-and-telecom-stocks-you-may-want-to-dump-in-june"> Top 2 Tech And Telecom Stocks You May Want To Dump In June</a></li>
</ul>

Markets

Trading Ideas

New Oriental Education & Technology Group

GOOGL

This Alphabet Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday

HSBC analyst Erwan Rambourg upgrades Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) from Hold to Buy and raises the price target from $80 to $99.

HSBC Upgrades Estee Lauder Cos to Buy, Raises Price Target to $99

Channel Therapeutics Corporation, ("Channel" or the "Company"), (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#NYSE">CHRO</a>), an emerging leader in the development of non-opioid pain treatment therapeutics, today announced a 10-for-one reverse split (the "Reverse Stock Split") of the Company's common stock (the "Common Stock"). The Reverse Stock Split is intended to increase the market price per share of the Company's Common Stock and help the Company satisfy the initial listing requirements of the NYSE American (the "NYSE American") in connection with the anticipated closing of the previously announced merger of CHRO Merger Sub, Inc., a wholly owned subsidiary of the Company, with and into LNHC, Inc. and the related approximately $50 million in capital to be raised from a group of strategic investors led by Murchinson (together, the "Proposed Transactions").

Stock Split

CHRO

Channel Therapeutics Announces 10-For-1 Reverse Split Ahead Of LNHC Merger, $50M Investment Led By Murchinson

Platinum prices have surged to their highest levels since 2014, driven by tightening supply, speculative investor flows, and a wave of buyers turning to the metal as a cheaper alternative to gold.
The <a target="_blank" href="https://www.benzinga.com/topic/platinum" rel="noreferrer noopener">precious metal</a> climbed as high as $1,435 per ounce in the Asian trading session on Friday before taking a breather in the rally that gained over 50% from the April lows.
A key catalyst behind the rally is a deepening supply deficit. The World Platinum Investment Council (WPIC) recently noted that the platinum market is expected to record a deficit of 966 koz this year, followed by 992 koz and 896 koz in 2024 and 2023, respectively.
Also Read: <a href="https://www.benzinga.com//node/45858594">Platinum Rallies To 4-Year High: Is $1,200 Just The Start?</a>
"On the supply side, mine production remains at multi-year lows, while recycling has failed to rebound to pre-pandemic levels, " Edward Sterck, WPIC's Director of Research, <a target="_blank" href="https://platinuminvestment.com/about/60-seconds-in-platinum/2025/06/18" rel="noreferrer noopener">said </a>in the report published on June 18.
Sterck noted that demand, while down 4% year-on-year due to lower industrial glass demand, remains resilient. "Jewelry and investment demand are outperforming expectations, with bar and coin sales in China in particular showing strong momentum," he added.
Much of the current demand boom is being driven by jewelry and technological applications. In China, gold jewelry sales plummeted 32% in the first quarter, while platinum jewelry fabrication <a target="_blank" href="https://platinuminvestment.com/files/873451/WPIC_Platinum_Quarterly_Q1_2025.pdf" rel="noreferrer noopener">rose by 26%</a> as consumers sought a more affordable alternative. Retailers responded by boosting their platinum inventories.
Technology-driven demand is also a factor, as platinum (traditionally a component of catalyst converter metals for internal combustion engines) plays a crucial role in hydrogen energy systems, particularly in proton exchange membrane electrolyzers.
Another factor driving platinum's momentum is its growing role as a "gold alternative." With gold trading at historic highs above $3,000 an ounce and institutions like Goldman Sachs seeing a further <a target="_blank" href="https://www.goldmansachs.com/insights/articles/why-gold-prices-are-forecast-to-rise-to-new-record-highs" rel="noreferrer noopener">rise to $3,700</a> by the end of 2025, platinum remains notably undervalued in comparison.
This widening price gap between the two metals has made platinum an increasingly attractive option for investors seeking exposure to precious metals without paying gold's premium.
"Gold has almost doubled in two years," Nicky Shiels of MKS Pamp said according <a target="_blank" href="https://www.ft.com/content/69d15526-97d2-476a-9699-e341f26118f2" rel="noreferrer noopener">to</a> the Financial Times, "and this is the next iteration of that trade—investors are asking ‘what's next?' and platinum is answering that call."
Looking ahead, analysts expect the bullish trend in platinum to persist. WPIC forecasts continued deficits through 2029, citing structural weaknesses in supply and growing industrial and investment demand. With visible above-ground stocks declining and no significant recovery in mine production anticipated soon, the fundamentals suggest further price upside.
Price Watch: Valterra Platinum (OTCPK: AGPPF) closed at $45.41. The stock is up nearly 45% year-to-date.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/46006672" target="_blank" rel="noreferrer noopener">Options Corner: Safe-Haven Demand Could Spark A Golden Payout For This Royal Gold Call Spread</a></li>
</ul>
Photo by yMediaStock via Shutterstock

Large Cap

Commodities

AGPPF

PALL

PGMFF

First Trust ISE Global Platinum Index Fund

PLTM

PPLT

Investors Seek Gold Alternative - Platinum Hits $1,400 As Supply Deficit Deepens

A man who retired at 49 with a steady $4,000 monthly pension and a paid-off home now finds himself drowning in $85,000 in personal loans plus another $5,000 in credit card debt. At 65, he's asking his sons for $1,000 a month to help stay afloat.
The problem? His kids are in their prime working years and have their own financial responsibilities, including plans to fund graduate school.
During a <a href="https://www.youtube.com/watch?v=JVkQdBtsuoc">recent episode</a> of "The Ramsey Show," co-hosts Jade Warshaw and John Delony didn't sugarcoat their advice: helping your parents is admirable — but not when it puts your own future at risk.
Don't Miss:
<ul class="wp-block-list">
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
</ul>
<h2 class="wp-block-heading">A Tough Ask From Dad</h2>
The caller said his father, mostly healthy after a recent minor heart attack, has been out of the workforce for over 15 years. His pension provides about $48,000 annually, and he typically gets an extra $7,000 to $12,000 in end-of-year bonuses.
Still, his loan payments total around $2,500 each month, leaving him short. To close the gap, he's asking his sons to front him $1,000 a month now, with a promise to pay them back when the bonus comes through.
But Ramsey personalities <a href="https://www.benzinga.com/personal-finance/management/25/06/46017023/this-dave-ramsey-caller-is-spending-half-his-78000-income-on-legal-fees-for-custody-battles-with-two-women-he-got-pregnant-in-college">Warshaw</a> and Delony said this isn't just a financial dilemma — it's an emotional one.
"He's put you and your brother in an incredibly awkward position," Delony said. "On behalf of dads everywhere, I'm sorry he did that to you. ‘Cause dads aren't supposed to do that to their boys."
Trending: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a>
<h2 class="wp-block-heading">Retired Too Early — And With Too Much Debt</h2>
Retiring at 49 is uncommon — and risky without serious <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/01/42805298/with-the-new-generation-beta-come-new-financial-planning-challenges-and-opportunities">financial planning</a>. The caller explained his dad spends his time on a small hobby farm, which might bring in $7,000 to $10,000 if sold, but isn't enough to offset the mounting debt.
Warshaw questioned the decision to walk away from the workforce so early, especially with loans still on the table. "He for sure has six good working years in him," she said, adding that he could bring in an extra $1,000 per month without putting pressure on his children.
<h2 class="wp-block-heading">The Money's Already Spoken For</h2>
The caller said he technically has the funds to help, but they're set aside for his wife's graduate school. Warshaw was quick to push back: "It's earmarked for something else, so that means you don't have it."
Using earmarked money, especially for long-term goals like education, can sabotage a couple's <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/06/46024255/7-silent-wealth-drains-that-are-sabotaging-your-future">financial future</a> and strain the marriage in the process.
<h2 class="wp-block-heading">Time for a Wake-Up Call</h2>
Delony emphasized the need for an honest conversation between father and sons. "You&#8217;re broke, man," he said, describing what the son needs to tell his father directly.
That conversation should include hard questions: Is Dad willing to return to work? Sell assets? Downsize? Or is he simply looking for an easier way out — one that comes at his children's expense?
See Also: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Now Raising at $3/Share</a>
According to Delony, it's not about being ungrateful or harsh — it's about setting boundaries and making responsible choices. He said it would be different if the caller's father didn't have food or shelter, but "this isn't that."
<h2 class="wp-block-heading">Love, Support — And Limits</h2>
Warshaw and Delony both stressed that while supporting aging parents is an honorable thing to do, it shouldn't come at the cost of your own stability.
"He put a wedge in y&#8217;all&#8217;s father-son relationship by saying, ‘Hey, I know your wife&#8217;s in school. I know y&#8217;all are thinking about having a family. I know y&#8217;all are thinking these things. I don&#8217;t care," Delony said. "Don&#8217;t further that wedge by creating a business transaction between the two of you."
At the end of the day, love doesn't always mean saying yes. In this case, as Ramsey's team made clear, saying no may be the most loving — and responsible — choice of all.
Read Next: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>

Personal Finance

He Retired At 49 With A $4K Monthly Pension, But His $85K Debt Has Him Asking His Kids For Help – 'Ramsey Show' Hosts Weigh

Wells Fargo analyst Sam Reid maintains Toll Brothers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) with a Overweight and raises the price target from $125 to $130.

Wells Fargo Maintains Overweight on Toll Brothers, Raises Price Target to $130

Stephens &amp; Co. analyst Trey Grooms downgrades GMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) from Overweight to Equal-Weight and maintains the price target from $95 to $95.

Downgrades

Stephens & Co. Downgrades GMS to Equal-Weight, Maintains Price Target to $95

Wells Fargo analyst Sam Reid maintains KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) with a Underweight and lowers the price target from $52 to $50.

Wells Fargo Maintains Underweight on KB Home, Lowers Price Target to $50

Wells Fargo analyst Joseph O'Dea maintains Acuity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) with a Equal-Weight and raises the price target from $285 to $320.

Wells Fargo Maintains Equal-Weight on Acuity, Raises Price Target to $320

Google Labs, Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google&#8217;s home for AI experiments, <a href="https://blog.google/technology/google-labs/doppl/" target="_blank" rel="noreferrer noopener">introduced</a> a new fashion-centric AI app aimed at style enthusiasts and digital creatives.
The experimental tool, called Doppl, leverages advanced artificial intelligence to help users explore and visualize how different outfits might appear on animated avatars of themselves.
Doppl expands on Google&#8217;s previous virtual try-on feature by introducing new experimental elements.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/46134725/google-cloud-hires-former-oracle-cfo-as-ai-race-heats-up" rel="noreferrer noopener">Google Cloud Hires Former Oracle CFO As AI Race Heats Up</a>
Users can upload images, whether personal snapshots or screenshots from the web, and see how those outfits might look on themselves using a lifelike digital model.
This includes both still previews and animated renderings that simulate motion and fabric flow.
The app allows users to store their favorite looks, share them across social platforms, and refine their personal style based on inspiration drawn from real-life encounters or online discovery.
Whether the outfit is seen on a friend or in a store window, Doppl turns a single image into a personalized fashion experience.
Developed under the umbrella of Google Labs, Doppl remains in an early testing phase.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, GOOG stock has lost over 6% in the past year. Investors can gain exposure to the stock via&nbsp;ETF Opportunities Trust T-Rex 2X Long Alphabet Daily Target ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/GOOX#BATS">GOOX</a>).
Price Action: GOOG shares are trading higher by 0.37% to $175.08&nbsp;at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46132953/fake-news-former-engineer-joining-meta-refutes-sam-altmans-100m-golden-pass-accusation-to-poach-openai-talent" target="_blank" rel="noreferrer noopener">&#8216;Fake News:&#8217; Former Engineer Joining Meta Refutes Sam Altman&#8217;s $100M Golden Pass Accusation To Poach OpenAI Talent</a></li>
</ul>
Image via Shutterstock

Equities

Tech

General

GOOG

ETF Opportunities Trust T-Rex 2X Long Alphabet Daily Target ETF

GOOX

Try Any Outfit At Home Before Buying - Google Drops New AI App

Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>, BBLGW))), a developer of orthobiologic products for spine fusion markets, today announced the pricing of its public offering of an aggregate of 1,250,000 shares of its common stock (or common stock equivalents in lieu thereof), Series D warrants to purchase up to 1,250,000 shares of common stock and Series E short-term warrants to purchase up to 1,250,000 shares of common stock, at a public offering price of $4.00 per share (or common stock equivalent in lieu thereof) and accompanying warrants. The Series D warrants will have an exercise price of $4.00 per share, will be exercisable immediately upon issuance and will expire five years after the date of issuance, and the Series E short-term warrants will have an exercise price of $4.00 per share, will be exercisable immediately upon issuance and will expire 18 months after the date of issuance. The closing of the offering is expected to occur on or about June 30, 2025, subject to the satisfaction of customary closing conditions.
Total gross proceeds to the Company from the offering, before deducting the placement agent's fees and other offering expenses, are expected to be $5.0 million. The potential additional gross proceeds to the Company from the warrants, if fully-exercised on a cash basis, will be $10.0 million. No assurance can be given that any of such warrants will be exercised. The Company intends to use the net proceeds from this offering to fund clinical trials, maintain and extend its patent portfolio, and for working capital and other general corporate purposes. &nbsp;

Offerings

BBLG

BBLGW

Bone Biologics Prices $5M Public Offering At $4.00/Shr With Series D And E Warrants

<h2 class="wp-block-heading">New On The Block</h2>
Bahama Breeze may soon be <a href="https://www.benzinga.com/general/restaurants">gone with the wind</a>. 
Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) is considering selling the Caribbean-inspired chain or repurposing all its locations.
The decision comes after Darden closed 15 Bahama Breeze restaurants in May, leaving just 28. Guru Focus <a href="https://www.gurufocus.com/news/2938406/darden-to-explore-strategic-alternatives-for-bahama-breeze-chain?r=caf6fe0e0db70d936033da5461e60141">reported</a> that CEO Rick Cardenas told analysts that future investments in the brand are off the table.
Initially launched in the 1990s, Bahama Breeze served up tropical vibes with dining options like coconut shrimp and empanadas. However, after a strategic review, Darden decided it was time to focus on other properties, such as the never-ending-pasta-bowl innovator Olive Garden.
<h2 class="wp-block-heading">Updates From The Block</h2>
Businessman Mark Walter has agreed to acquire a majority stake in the NBA's Los Angeles Lakers from the Buss Family Trust. Jeanie Buss will continue to oversee team operations. Walter, already a minority owner, also leads TWG Global, which holds stakes in several sports properties.
The Buss family has owned the Lakers since 1979, overseeing 11 NBA championships and shaping one of the most recognized franchises in global sports. The team has featured iconic players such as Magic Johnson, Kareem Abdul-Jabbar, Kobe Bryant, Shaquille O'Neal and LeBron James.
The deal is expected to close in late 2025, pending NBA approval and other standard conditions.
Guggenheim Securities is advising Walter, with legal support from Davis Polk &amp; Wardwell LLP. ArentFox Schiff LLP represents the Lakers and the Buss Family Trust.
More Updates:
<ul class="wp-block-list">
<li>Recall in 2021 how Best Buy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) acquired remote care management platform Current Health. It&#8217;s now selling it <a href="https://www.linkedin.com/feed/update/urn:li:activity:7343300338491305984/">back</a> to co-founder Christopher McGhee for $400 million.</li>
<li>Maserati isn&#8217;t for sale. That&#8217;s according to Stellantis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>), the owner, which <a href="https://www.reuters.com/business/autos-transportation/jeep-maker-stellantis-weighs-sale-among-options-maserati-sources-say-2025-06-20/?utm_source=newsletter&amp;utm_medium=email&amp;utm_campaign=newsletter_axioscloser&amp;stream=top">responded</a> to a Reuters report.</li>
<li>U.S. antitrust regulators approved Mars&#8216; proposed $35.9 billion purchase of snackmaker Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>). In Europe, however, antitrust <a href="https://www.benzinga.com/m-a/25/06/46113916/mars-just-got-the-green-light-for-its-36b-deal-but-europe-might-blow-it-up">regulators are investigating the deal</a>.</li>
<li>New Zealand-based accounting software firm Xero will acquire U.S. bill-pay platform Melio for an initial $2.5 billion, according <a href="https://www.wsj.com/business/deals/xero-to-buy-melio-for-initial-2-5-billion-in-u-s-growth-play-eb0d46af?mod=deals_news_article_pos2">to</a> the Wall Street Journal. Melio shareholders, including Accel and Thrive Capital, will receive $360 million in Xero shares. Xero, which reported approximately $1.26 billion in revenue for its last fiscal year, stated that revenue could double over the next three years, excluding anticipated synergies. Melio CEO Matan Bar will lead Xero's U.S. business post-acquisition.</li>
<li>Bank of New York Mellon placed an offer for Chicago-based Northern Trust, which has a market value of more than $21 billion. The Trump administration has <a href="https://www.reuters.com/markets/deals/big-bank-deals-stalled-by-trump-volatility-even-officials-signal-deregulation-2025-03-14/">signaled</a> a greater willingness to approve large banking deals, but few have been completed.</li>
<li>Woody Johnson is the latest rich American to buy a different football club. The billionaire agreed to pay just $215 million for a &#8220;significant&#8221; stake in Premier League club Crystal Palace, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-06-23/ny-jets-owner-woody-johnson-agrees-deal-for-crystal-palace-stake?sref=TBDibEcD">reports</a>. On the sell side is John Textor. Let&#8217;s hope Crystal Palace has better luck than the New York Jets, which has been under the miserable ownership of Johnson since January 2000.</li>
<li>Unilever signed an agreement to acquire personal care brand Dr. Squatch from growth equity firm Summit Partners. The price tag was not disclosed, but Women&#8217;s Wear Daily <a href="https://wwd.com/beauty-industry-news/skin-care/unilever-personal-care-acquisition-dr-squatch-1237941602/">reported</a> that the company&#8217;s sales exceeded $400 million.</li>
</ul>
<h2 class="wp-block-heading">Off The Block</h2>
<ul class="wp-block-list">
<li>The NBA&#8217;s board of governors approved the $1.5 billion sale of the Minnesota Timberwolves and WNBA's Minnesota Lynx from longtime owner Glen Taylor to an investment group led by entrepreneur Marc Lore and former MLB star Alex Rodriguez. The unanimous vote concludes a four-year back-and-forth process that included arbitration after Taylor attempted to cancel the deal earlier this year. Taylor, who bought the Timberwolves in 1994 to prevent a relocation to New Orleans, leaves after 31 years with the team. Lore and Rodriguez pledged to keep the teams in Minnesota.</li>
</ul>
<ul class="wp-block-list">
<li>Parkland (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PKI#TSX">PKI</a>), a Canadian fuel distributor, confirmed that shareholders voted in favor of a $9.1 billion takeover by Sunoco (YSE: SUN). The deal will form America&#8217;s largest independent fuel distributor.</li>
</ul>
<h2 class="wp-block-heading">Bankruptcy Block</h2>
<ul class="wp-block-list">
<li>You can still place bids on assets owned by Monster and CareerBuilder. The two online job search websites, which merged last year, <a href="https://www.wsj.com/articles/careerbuilder-monster-to-sell-businesses-in-bankruptcy-9daa38dd">filed</a> for Chapter 11 bankruptcy. So far, JobGet is looking to buy at least one asset. Canada-based Valsoft Corporation and Canadian media firm Valnet are keen on acquiring others, including Military.com, which Monster bought in 2004 for $39.5 million. Tough competition is to blame for the restructuring, says CEO Jeff Furman, citing Indeed, LinkedIn, and Glassdoor. Private equity firm Apollo Global Management holds a minority stake in the company.</li>
</ul>
<a href="https://www.benzinga.com/m-a/25/06/46038749/deal-dispatch-boston-red-sox-owner-sets-sights-on-la-liga-club-at-home-files-for-bankruptcy">For last week&#8217;s edition of Deal Dispatch, click here</a>. 
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46125266/thank-you-elon-musks-longtime-aide-reportedly-fired-days-after-public-praise">&#8216;Thank You, Elon:&#8217; Musk&#8217;s Longtime Aide Reportedly Fired Days After Public Praise</a></li>
</ul>
Image: Edited by Benzinga using Shutterstock

Asset Sales

Sports

STLA

TSX:PKI

Deal Dispatch: Darden Cools On Bahama Breeze, NBA M&A Heats Up

Wells Fargo analyst Finian O'Shea maintains Ares Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCC#NASDAQ">ARCC</a>) with a Overweight and raises the price target from $21 to $22.

ARCC

Wells Fargo Maintains Overweight on Ares Capital, Raises Price Target to $22

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">41.27</td>
<td align="right">0.30</td>
<td align="right">0.73</td>
<td>1.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">216.37</td>
<td align="right">1.36</td>
<td align="right">0.63</td>
<td>4.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">106.96</td>
<td align="right">0.53</td>
<td align="right">0.49</td>
<td>105</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">146.00</td>
<td align="right">0.66</td>
<td align="right">0.45</td>
<td>673</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">81.45</td>
<td align="right">0.28</td>
<td align="right">0.34</td>
<td>3.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">86.03</td>
<td align="right">0.28</td>
<td align="right">0.32</td>
<td>35.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">251.60</td>
<td align="right">0.53</td>
<td align="right">0.21</td>
<td>14.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">87.96</td>
<td align="right">0.18</td>
<td align="right">0.20</td>
<td>880</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">134.47</td>
<td align="right">0.25</td>
<td align="right">0.18</td>
<td>3.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">51.85</td>
<td align="right">0.06</td>
<td align="right">0.11</td>
<td>292.6K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">80.15</td>
<td align="right">-0.02</td>
<td align="right">-0.03</td>
<td>1.5K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For June 27, 2025

U.S. stock futures were higher this morning, with the Dow futures gaining over 100 points on Friday.
Shares of Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) fell sharply in today's pre-market trading after the company posted mixed <a href="https://www.benzinga.com/quote/CNXC/earnings">second-quarter results</a>.
Concentrix reported quarterly earnings of $2.70 per share, which missed the analyst consensus estimate of $2.75. Quarterly revenue came in at $2.42 billion, which beat the Street estimate of $2.38 billion
Concentrix shares dipped 8% to $50.70 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>CorMedix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) declined 14.2% to $12.83 in pre-market trading after the company announced an $85 million public offering.</li>
<li>Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) fell 14.2% to $3.14 in pre-market trading after surging more than 32% on Thursday.</li>
<li>AdaptHealth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHCO#NASDAQ">AHCO</a>) fell 8.6% to $8.61 in pre-market trading after gaining around 5% on Thursday.</li>
<li>USA Rare Earth, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USAR#NASDAQ">USAR</a>) declined 8.4% to $11.65 in pre-market trading.</li>
<li>Gold Fields Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFI#NYSE">GFI</a>) fell 5.1% to $22.60 in pre-market trading.</li>
<li>OMS Energy Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMSE#NASDAQ">OMSE</a>) fell 4.6% to $6.80 in pre-market trading.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46115042/top-2-tech-and-telecom-stocks-you-may-want-to-dump-in-june">Top 2 Tech And Telecom Stocks You May Want To Dump In June</a> </li>
</ul>
Photo via Shutetrstock

AHCO

CNXC

CRMD

CRML

OMSE

USAR

Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Press Releases

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Earnings

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Health Care

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy

Comments

Bionano Genomics

Notizie

Ultime notizie per Bionano Genomics (NASDAQ:BNGO) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO